Canopy Growth Corporation announced the release of its Environmental, Social, and Governance (ESG) Report (“the Report”) for calendar year 2020, as well as qualitative details on some key activities that occurred in 2021. The Report recognizes Canopy’s current progress and describes its priorities and approach to ESG as part of its long-term path towards responsible and sustainable growth.
“As the cannabis industry becomes more established, we recognize the role we must play to ensure that progress is achieved responsibly and sustainably,” said David Klein, CEO Canopy Growth. “We are committed to realizing our vision of unleashing the power of cannabis to improve lives and our inaugural ESG report is the next step in our leadership journey, creating accountability for ourselves, and the cannabis industry.”
Key Highlights
- Conducted our first-ever baseline assessment of our Scope 1 and Scope 2 energy use and GHG emissions
- Invested over $1 million in supporting record-clearing, wrap-around and ancillary services for people impacted by the war on drugs
- Registered 23,000 patients for our Compassionate Pricing Program through Spectrum Therapeutics
- Hired our first Vice President of Diversity Equity & Inclusion in 2021 and established Employee Resource Groups representing Indigenous, Black and LGBTQ2S+ employees and employees living with disabilities
- Achieved near gender parity of women in our global workforce
- Trained 93% of Canopy Growth employees on our pharmacovigilance program
- Recorded 0 safety-related product recalls globally
Disclosures within the Report are made using relevant reporting standards and frameworks including the Sustainability Accounting Standards Board (SASB) Biotechnology & Pharmaceuticals, Agricultural Products, and Non-Alcoholic Beverages Sustainability Accounting Standards and the UN Sustainable Development Goals.
As the first cannabis company in North America to be publicly traded, federally regulated, and licensed in Canada as a cannabis producer, Canopy Growth embraces its opportunity and responsibility to be a part of the cannabis industry’s efforts to move forward with integrity and intention. To read the report in full, please view here.
About Canopy Growth
Canopy Growth is a world-leading diversified cannabis and cannabinoid-based consumer product company, driven by a passion to improve lives, end prohibition, and strengthen communities by unleashing the full potential of cannabis. Leveraging consumer insights and innovation, we offer product varieties in high-quality dried flower, oil, softgel capsule, infused beverage, edible, and topical formats, as well as vaporizer devices by Canopy Growth and industry-leader Storz & Bickel. Our global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both Canada and Germany. For more information visit www.canopygrowth.com.
